Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. 4 Insider Changes in Ownership
  2. 424B4 Offering Prospectus
  3. POS EX Other Post-effective Amendment
  4. S-1MEF Other S-1MEF
  5. EFFECT Other Notice of Effectiveness
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-1/A Offering Registration Statement
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. 8-K Event Other events
  11. 4 Insider Changes in Ownership
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. S-1/A Offering Registration Statement
  16. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  17. S-1/A Offering Registration Statement
  18. 8-K Event Other events
  19. 424B3 Offering Prospectus
  20. EFFECT Other Notice of Effectiveness

Page 28 of 42 · 833 filings